• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
NI Hua, PENG Jia-qing. Analysis of related factors in maintenance hemodialysis patients with renal anemia[J]. Journal of Clinical Nephrology, 2017, 17(7): 427-430. DOI: 10.3969/j.issn.1671-2390.2017.07.011
Citation: NI Hua, PENG Jia-qing. Analysis of related factors in maintenance hemodialysis patients with renal anemia[J]. Journal of Clinical Nephrology, 2017, 17(7): 427-430. DOI: 10.3969/j.issn.1671-2390.2017.07.011

Analysis of related factors in maintenance hemodialysis patients with renal anemia

More Information
  • Received Date: October 27, 2016
  • Rev Recd Date: March 30, 2017
  • Available Online: May 11, 2023
  • Published Date: July 27, 2017
  • Objective To observe the renal anemia in maintenance hemodialysis (MHD) patients, analyze the related factors, and understand the relationship between hepcidin expression level and renal anemia in MHD patients.Methods This cross-sectional study was carried out in 128 MHD patients, including72 males and 56 females, with a mean age of (53.50±13.26) years and a mean dialysis vintage of (32.13±17.04) months from August 1 to 28, 2016. The clinical data of the patients were collected, and parameters such as routine blood test, C-reactive protein (CRP), Hepcidin, serum iron, ferritin, unsaturated iron-binding capacity (UIBC), electrolyte, folic acid, vitamin B12, parathyroid gland hormone (iPTH) and electrolyte were measured before the mid-week hemodialysis. Blood creatinine and urea nitrogen were detected before and after dialysis, and single chamber urea clearance index (sp Kt/V) was calculated.Results The mean hemoglobin in 128 patients was (98.54±16.93) g/L. Among them, hemoglobin ranged in 110-120 g/L in 28 cases, accounting for 22%. Pearson correlation analysis showed that hemoglobin was significantly positively correlated with leukocyte (r=0.279, P=0.001), erythrocrit (r=0.279, P=0.002), serum iron (r=0.188, P=0.033) and dialysis adequacy (r=0.215, P=0.015), but negative with hepcidin (r=-0.302, P=0.001), serum ferritin (r=-0.207, P=0.019), UIBC (r=-0.195, P=0.027), iPTH (r=-0.264, P=0.003) and C reaction protein (r=-0.203, P=0.022). Multiple linear stepwise regression model results suggested that the hemoglobin protein was positively correlated with erythrocrit (P<0.01), but negatively with hepcidin (P=0.001) and iPTH (P<0.05).Conclusions Anemia in MHD patients is closely related with number of white blood cells, hematocrit, hepcidin, serum iron, dialysis adequacy, UIBC, iPTH, C reaction protein, serum iron and other factors, Little correlation with folic acid and vitamin B12.
  • [1]
    Shaheen FA, Souqiyyeh MZ, Al-Attar BA, et al. Prevalence of anemia in predialysis chronic kidney disease patients[J]. Saudi J Kidney Dis Transpl, 2011, 22(3):456-463.
    [2]
    林攀, 丁小强, 袁敏, 等. 慢性肾脏病患者贫血患病现况调查[J]. 复旦学报(医学版), 2009, 36(5):562-565.
    [3]
    Richardson D. Clinical factors influencing sensitivity and response to epoetin[J]. Nephrol Dial Transplant, 2002, 17(S1):53-59.
    [4]
    Jing Z, Wei-jie Y, Nan Z, et al. Hemoglobin targets for chronickidney disease patients with anemia:a systematic review and meta-analysis[J]. PLo S One, 2012, 7(8):e43655.
    [5]
    Weiss G. Iron and anemia of chronic disease[J]. Kidney Int Suppl, 1999, 69(S):12-17.
    [6]
    Arici W, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality:is C-reactive protein the missing link?[J]. Kidey Int, 2001, 59(2):407-417.
    [7]
    倪华, 彭家清. 铁调素与慢性肾脏病肾性贫血患者铁代谢的关联[J]. 临床肾脏病杂志, 2016, 16(10):635-638.
    [8]
    Nakanishi T, Karagano T, NanamiM, et al. Improtance of fereintin for optimizing anemia therapy in chronic kidney disease[J]. Am J Nephrol, 2010, 32(5):439-446.
    [9]
    Ganz T. Molecular control of iron transport[J]. J Am Soc Nephrol, 2007, 18(2):394-400.
    [10]
    Swinkels DW, Wetzels JF. Hepcidin:a new tool in the management of anaemia in patients with chronic kidney disease?[J]. Nephrol Dial Transplant, 2008, 23(8):2450-2453.
    [11]
    刘惠兰, 王英, 姚英, 等. 尿毒症血液透析患者血浆瘦素水平与营养状态的研究[J]. 中华内科杂志, 2001, 40(2):109-111.
    [12]
    廖彦, 林翀. 尿毒症患者贫血原因调查分析[J]. 湖南医学, 1997, 14(7)S:107.
    [13]
    Parker BD, Schurgers LJ, Brandenburg VM, et al. The Association offibroblast growth factor 23 and uncarboxylated matrix Gla pro-tein with mortality in coronary artery disease:the Heart and Soul Study[J]. Ann Intern Med, 2010, 152(10):640-648.
    [14]
    张琳. 超敏CRP临床应用进展[J]. 河北医药, 2006, 28(6):519-521.
    [15]
    王宇静, 李兆, 段力平, 等. 维持性血液透析患者缺铁状态与微炎症的相关性研究[J]. 中华医院感染学杂志, 2016, 26(2):372-373, 382.
    [16]
    吴建平, 郭树龙, 沈世忠, 等.CAPD的内分泌激素与rHEPOu疗效的相关性[J]. 中国中西医结合肾病杂志, 2003, 4(4):218-220.
    [17]
    Poli M, Girelli D, Campostrini N, et al. Heparin:a potent inhibitor of hepcidin expression in vitro and in vivo[J]. Blood, 2011, 117(3):997-1004.
  • Related Articles

    [1]Wang Li-li, Yang Man-ling, Hou Jing, Wang Li-juan. Efficacy and safety of roxadustat in hemodialysis patients with renal anemia based upon the changes of erythropoietin, interleukin-6 and △Hbmax[J]. Journal of Clinical Nephrology, 2023, 23(5): 357-362. DOI: 10.3969/j.issn.1671-2390.2023.05.002
    [2]Zhang Peng-jie, Xun Li-ru, Ding Tong, Bao Nan, Duan Bin. Clinical efficacy and safety analysis in initial hemodialysis patient with renal anemia treated by roxadustat or recombinant human erythropoietin[J]. Journal of Clinical Nephrology, 2022, 22(11): 917-923. DOI: 10.3969/j.issn.1671-2390.2022.11.006
    [3]Hua Rui-xue, Zou Lu-xi, Wu Yu, Sun Ling. Effect of dialysate glucose on synthesis of serum hepcidin in patients on maintenance hemodialysis[J]. Journal of Clinical Nephrology, 2022, 22(5): 359-364. DOI: 10.3969/j.issn.1671-2390.2022.05.002
    [4]XU Leng-nan, CHEN Xian-guang, LI Chuan-bao, LIU Xin, SUN Ying, MAO Yong-hui. Significance of reticulocyte hemoglobin content in the treatment of anemia in maintenance hemodialysis patients[J]. Journal of Clinical Nephrology, 2020, 20(11): 853-856. DOI: 10.3969/j.issn.1671-2390.2020.11.001
    [5]SU Chao, BIAN Xian-qian, WANG Gang, ZHANG Qu, DU Ting-ting, HE Heng-jie. The difference of efficacy between Shengxuening and Polysaccharide iron complex capsule in treating renal anemia in patients with hemodialysis[J]. Journal of Clinical Nephrology, 2020, 20(4): 293-296,321. DOI: 10.3969/j.issn.1671-2390.2020.04.006
    [6]HE Zhang-xiu, LUO Lei, XIE Huan, ZHAO Sai-li. Epidemiology of anemia in patients with chronic kidney disease of stages 3-5D: a cross-sectional study in Hengyang, South of Hunan province, China[J]. Journal of Clinical Nephrology, 2019, 19(1): 8-13. DOI: 10.3969/j.issn.1671-2390.2019.01.002
    [7]ZHANG Yong, HOU Juan. Efficacy of L-carnitine combined with erythropoietin in the treatment of hemodialysis-induced renal anemia[J]. Journal of Clinical Nephrology, 2018, 18(3): 176-179. DOI: 10.3969/j.issn.1671-2390.2018.03.011
    [8]LU Qing-hong, LI Yi-ming, SHI Ming. Effect of L-carnitine on oxidative stress in maintenance hemodialysis patients with anemia[J]. Journal of Clinical Nephrology, 2017, 17(10): 590-593. DOI: 10.3969/j.issn.1671-2390.2017.10.003
    [9]TANG Dai-rong, XIE Xian-da, LIAO Xiang-ping. Clinical significance of urine hepcidin in lupus nephritis[J]. Journal of Clinical Nephrology, 2017, 17(8): 490-494. DOI: 10.3969/j.issn.1671-2390.2017.08.009
    [10]MA Chun-yuan, HE Zhang-xiu, ZHOU Yang, HAO Li-rong. Epidemiology of anemia in patients with stages 3-5D chronic kidney disease: a cross-sectional study in Harbin, Northeast China[J]. Journal of Clinical Nephrology, 2017, 17(4): 205-210. DOI: 10.3969/j.issn.1671-2390.2017.04.003

Catalog

    Article views (16) PDF downloads (280) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return